Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.
3.
4.
5.

Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial.

Misra UK, Kalita J, Yadav RK.

J Headache Pain. 2007 Jun;8(3):175-9. Epub 2007 Jun 11.

6.

Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.

Savi L, Mogavero S, Egan CG.

Drug Des Devel Ther. 2014 Jul 21;8:983-92. doi: 10.2147/DDDT.S61295. eCollection 2014.

7.

Long-term efficacy and tolerability of rizatriptan wafers in migraine.

Cady R, Crawford G, Ahrens S, Hairwassers D, Getson A, Visser WH, Lines C; Rizatriptan-RPD Study Group.

MedGenMed. 2001 Jun 1;3(3):1.

8.

Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.

Lipton RB, Pascual J, Goadsby PJ, Massiou H, McCarroll KA, Vandormael K, Jiang K, Lines CR.

Headache. 2001 Sep;41(8):754-63.

PMID:
11576198
9.

Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.

Visser WH, Winner P, Strohmaier K, Klipfel M, Peng Y, McCarroll K, Cady R, Lewis D, Nett R; Rizatriptan Protocol 059 and 061 Study Groups.

Headache. 2004 Oct;44(9):891-9.

PMID:
15447698
10.

Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.

Seeburger JL, Taylor FR, Friedman D, Newman L, Ge Y, Zhang Y, Hustad CM, Lasorda J, Fan X, Hewitt D, Ho T, Connor KM.

Cephalalgia. 2011 May;31(7):786-96. doi: 10.1177/0333102410390399. Epub 2010 Nov 15.

PMID:
21078681
11.

Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.

Pascual J, Bussone G, Hernandez JF, Allen C, Vrijens F, Patel K; Rizatriptan-Sumatriptan Preference Study Group.

Eur Neurol. 2001;45(4):275-83.

PMID:
11385269
12.
13.

Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.

Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.

Headache. 2012 Jan;52(1):57-67. doi: 10.1111/j.1526-4610.2011.02027.x. Epub 2011 Nov 11.

PMID:
22078129
14.

Early treatment of migraine with rizatriptan: a placebo-controlled study.

Mathew NT, Kailasam J, Meadors L.

Headache. 2004 Jul-Aug;44(7):669-73.

PMID:
15209688
15.

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.

Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L.

J Headache Pain. 2011 Dec;12(6):609-15. doi: 10.1007/s10194-011-0366-9. Epub 2011 Aug 13.

16.

Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine.

Silberstein S, Tepper S, Brandes J, Diamond M, Goldstein J, Winner P, Venkatraman S, Vrijens F, Malbecq W, Lines C, Visser WH, Reines S, Yuen E.

Neurology. 2004 May 11;62(9):1552-7.

PMID:
15136680
17.

Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.

Bomhof M, Paz J, Legg N, Allen C, Vandormael K, Patel K.

Eur Neurol. 1999;42(3):173-9.

PMID:
10529545
18.

Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial.

Saper J, Dahlof C, So Y, Tfelt-Hansen P, Malbecq W, Loeys T, Barraclough E, Klipfel M, Lines C, Visser H, Reines S, Yuen E; Rofecoxib Protocol 162 Study Group.

Headache. 2006 Feb;46(2):264-75.

PMID:
16492236
19.

Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.

Tuchman M, Hee A, Emeribe U, Silberstein S.

CNS Drugs. 2006;20(12):1019-26.

PMID:
17140280
20.

Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.

Christie S, Göbel H, Mateos V, Allen C, Vrijens F, Shivaprakash M; Rizatriptan-Ergotamine/Caffeine Preference Study Group.

Eur Neurol. 2003;49(1):20-9.

PMID:
12464714

Supplemental Content

Support Center